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Aim: The objective of this study was to determine the prevalence of COPD and its associated 
factors among adults in Albania. 
Methods: This was a cross-sectional study conducted in Albania in 2013-14. A nation-wide rep-
resentative sample of 1200 adults aged ≥40 years was selected using multistage cluster sampling 
technique. All participants were interviewed about socio-demographic characteristics, respiratory 
symptoms, smoking status and clinical characteristics. Spirometry was performed according to 
standard methods. COPD was defined as post-bronchodilator FEV1/FVC ratio <70% predicted. 
Results: Of the 1200 adults invited to participate, 939 adults or 78% (467 men and 472 women) 
were eligible for the study. The overall COPD prevalence (GOLD stage 1 or higher) was 12.4%; 
it was higher in men (17.4%) than in women (7.7%). Using Lower Limit of Normal (LLN), the 
prevalence of COPD was 9.9%, again higher in men (13.2%) than women (6.6%). The prevalence 
of doctor-diagnosed COPD was 1.3% (1.9% in men, 0.6 % in women). Male sex, smoking and 
increasing age were significantly associated with COPD diagnosis. 
Conclusion: The overall prevalence of COPD in Albania was 9.9% using BOLD standards. Smok-
ing and increasing age were the main risk factors for COPD. The study highlights the importance 
of raising awareness of COPD among health professionals. 
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Chronic Obstructive Pulmonary Disease 
(COPD) is currently the fourth leading cause 
of death in the world but is projected to be the 
3rd leading cause of death by 2020 (1). Glob-
ally, the COPD burden is projected to in-
crease in coming decades because of contin-
ued exposure to COPD risk factors and aging 
of the population (2). 
COPD prevalence, morbidity and mortality 
vary across countries and across different 
groups within countries. COPD is the result 
of a complex interplay of long-term cumula-
tive exposure to noxious gases and particles, 
combined with a variety of host factors in-
cluding genetics, airway hyper-responsive-
ness and poor lung growth during childhood 
(3,4). Often, the prevalence of COPD is di-
rectly related to the prevalence of tobacco 
smoking, although in many countries out-
door, occupational and indoor air pollution 
(resulting from the burning of wood and other 
biomass fuels) are major COPD risk factors 
(5,6).  
Despite a growing burden, COPD is often a 
neglected disease and its epidemiology is 
largely unknown in particular in low and 
middle income countries (7). Existing COPD 
prevalence data vary widely due to differ-
ences in survey methods, diagnostic criteria 
and analytical approaches (2). Many patients 
with COPD are still underdiagnosed, inade-
quately evaluated and under-recognized lead-
ing to significant underreporting of the dis-
ease (8,9). 
Community based studies using appropriate 
methods are needed to determine the epide-
miology of COPD and to enable the develop-
ment of prevention and management strate-
gies for the future.  
The Burden of Obstructive Lung Disease 
(BOLD) initiative aimed at developing and 
using a standardized method to measure the 
prevalence of COPD and its risk factors in 
various areas around the world (10,11). 
In our study, we used BOLD protocol to esti-




BOLD developed standardized methods in-
cluding standardized spirometry equipment, 
meticulous quality control measures, stand-
ard protocols, validated and translated ques-
tionnaires and standard data entry and analy-
sis. 
BOLD Operations Centre (OC) emphasized 
data quality control at every stage of the pro-
cess. The study was conducted in close colla-
boration with the BOLD Operations Centre 
(OC) in London which provided oversight, 
training, materials, quality control, and data 
analysis. 
National Bioethics Committee’s approval 
was a prerequisite for study implementation. 
 
Study design 
This was a cross-sectional study conducted in 
Albania in 2013-14, which consisted of a 
COPD prevalence survey among adults aged 
≥40 years. A representative sample of adult 
individuals in this age range was asked to fill 
in the questionnaires and perform spirometry 
tests designed by BOLD. 
Target population and sampling procedure: A 
nation-wide representative sample was 
drawn. A multi-stage cluster sample of 1200 
individuals (600 men and 600 women) aged 
≥40 years was drawn based on the sampling 
frame (alias the target population) available 
from the national Institute of Statistics (INS-
TAT). BOLDOC in London, UK, reviewed 
and approved the sampling approach calcu-
lated by a local expert. 
Recruitment of participants: Participants 
were contacted through home visits and were 
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asked to provide an informed consent to 




Spirometry was performed by eight trained 
and certified technicians (EasyOne spirome-
ter; ndd Medizintechnik; Zurich, Switzer-
land). COPD was defined as a post-broncho-
dilator FEV1/FVC <70% predicted. Spirom-
etry data were sent electronically to the OC 
where each spirogram was reviewed and 
graded using ATS guidelines (12). 
Post bronchodilator spirometry tests were 
performed at least 15 min after achievement 
of at least 3 acceptable and 2 reproducible pre 
bronchodilator spirometry tests. 
The number of pack-years of cigarette smok-
ing was defined as the average number of cig-
arettes smoked per day divided by 20 (i.e., 
packs per day) times the duration of smoking 
in years. 
 
Data recording and analysis  
Data for BOLD study consisted of electroni-
cally generated spirometry records, responses 
to questionnaires administered to study par-
ticipants, individual tracking data, and aggre-
gate data about the target population. Our 
data were reported to OC for validation and 
analysis. Estimated population prevalence of 
COPD for the overall city population was 
computed using survey data methods in Stata 
v. 12 (Stata Corporation, College Station, 
TX, USA), and stratified by sex, age and 
smoking status. The study was conducted 
from October 2012 to December 2013. 
 
Results 
Of the 1200 adults invited to participate, 997 
(83%) of them were eligible for the study. 
Among them 11 participants were excluded 
because of lost spirometry data due to the 
faulty spirometer and 47 other participants 
due to unacceptable post BD spirometry.  
Table 2 shows that there were no differences 
between responders and non-responders who 
were eligible for the study, except for smok-
ing status and other co-morbid conditions 
(p<0.001 and p<0.007, respectively). Partici-
pants that were current smokers and those 
with co-morbid conditions were less likely to 
be responders. 
Table 3 shows the prevalence of smoking in 
Albania by sex and age. Overall, 21.6% of in-
dividuals ≥40 years old were smokers at the 
time of the study. Smoking was much more 
prevalent in males than in females. The per-
centage of smoker was higher in age group 
50-59. 
The overall prevalence of GOLD stage I or 
higher COPD was 12.4%, and was higher in 
male (17.4%) than female sex (7.7%) and in 
those >70-year old. 
Using Lower Limit of Normal (LLN) the 
prevalence of COPD was 9.9%, again higher 
in males (13.2%) than females (6.6%) and 
like using GOLD criteria was higher in indi-
viduals > 70 years old (Table 4).  
The prevalence of COPD was strongly re-
lated to smoking history expressed as pack 
years as shown in table 5. 
 Table 6 shows the prevalence of smoking in 
Albania by sex and age. Overall, 21.6% of 
individuals ≥ 40 years old were smokers at 
the time of the study. Smoking was much 
more prevalent in males than in females. 
The percentage of smokers was higher in 
age group 50-59.  The prevalence of doctor-
diagnosed COPD was much lower than spi-
rometry-confirmed COPD, with an overall 
estimate of 1.3% (1.9% in males, 0.6 % in 
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Table 1. Disposition of Study Participants for BOLD SITE: Tirana, Albania 
 
Outcome  Men Women Unknown Total 
Responders:     
Full data collected (Core Ques plus QC 
acceptable post BD spirometry)  
467 472 0 939 
Full data collected (Core Ques plus QC 
unacceptable post BD spirometry)  
27 20 0 47 
Full data collected (Spirometry data lost due to 
faulty spirometer)* 
2 9 0 11 
Total responders 496 501 0 997 
Non-responders:      
Partial data collected 51 49 0 100 
Refused (minimal data collected) 2 2 0 4 
Refused (no minimal data collected) 43 32 0 75 
Known to have temporarily left area 3 10 0 13 
Unreachable (couldn’t reach)† 4 5 0 9 
Total non-responders 103 98 0 201 
Ineligible:      
Deceased 1 1 0 2 
Permanently left catchment area 0 0 0 0 
Age ineligible 0 0 0 0 
Institutionalized  0 0 0 0 
Untraceable (bad address & phone)‡ 0 0 0 0 
Total ineligible 1 1 0 2 
Total selected for recruitment¶ 600 600 0 1200 
                * Some spirometry data was lost before it could be transferred, due to a faulty spirometer; 
                † Contact information apparently correct, but no response to contact attempts;  
                ‡ Contact information incorrect, no updated information available;  
                ¶ Number of responders + non-responders + ineligibles. 
 
Table 2. Comparison of responders* and non-responders† for Albania 
 
  Responders Non-responders P-value‡ 
Age 40-49 351 (36%) 81 (40%) 0.382 
 50-59 330 (33%) 55 (27%)  
 60-69 191 (19%) 40 (20%)  
 70+ 114 (12%) 25 (12%)  
Gender Male 494 (50%) 103 (51%) 0.768 
 Female 492 (50%) 98 (49%)  
Smoking status Current 213 (22%) 46 (23%) <0.001 
 Ex 148 (15%) 9 (4%)  
 Never 625 (63%) 146 (73%)  
Doctor diagnosed asthma, 
emphysema, CB or COPD 
Yes 64 (6%) 6 (3%) 0.056 
No 922 (94%) 194 (97%)  
Other co-morbid conditions 
Yes 260 (26%) 72 (36%) 0.007 
No 726 (74%) 129 (64%)  
                        * Responders are those who completed post-BD spirometry (regardless of QC scores) and the core questionnaire. 
                        † Non-responders are eligible individuals who are missing the core questionnaire and/or post-BD spirometry, but for whom the 
                 tabulated variable is known.  
               ‡ Two-sided p-value based on Pearson’s chi-square test
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Table 3. Estimated Population Prevalence (SE) of GOLD Stage 1 or higher COPD* by  
age and sex for Albania 
 
   Age-group    
Sex 40-49 50-59 60-69 70+ Total 
Male 3.8 (0.5) 10.0 (2.3) 28.4 (6.7) 52.5 (7.5) 17.4 (2.5) 
Female 2.3 (0.5) 4.1 (1.9) 17.0 (6.1) 14.7 (5.2) 7.7 (2.3) 
Total 3.0 (0.4) 7.0 (1.5) 22.4 (4.7) 32.3 (4.9) 12.4 (1.7) 
                        * Post-BD FEV1/FVC <70%.
 
Table 4. Estimated Population Prevalence (SE) of COPD in Tirana, Albania, using Lower 
Limit of Normal (LLN): Modified Stage 1 or higher COPD* by age and sex 
 (Local Equations)  
 
   Age-group   
Sex 40-49 50-59 60-69 70+ Total 
Male 4.2 (0.9) 5.3 (2.3) 21.2 (2.2) 41.2 (11.0) 13.2 (2.6) 
Female 3.8 (1.4) 4.1 (1.9) 12.3 (5.5) 10.7 (2.4) 6.6 (1.4) 
Total 4.0 (0.8) 4.7 (1.5) 16.5 (3.2) 24.9 (5.4) 9.9 (1.4) 
                  * Post-BD FEV1/FVC < LLN 
Table 5. Estimated Population Prevalence (SE) of GOLD Stage 1 or higher COPD*  
by pack years and sex in Tirana, Albania 
 
   Pack-years   
Sex Never smokers 0-10 10-20 20+ Total 
Male 6.2 (2.2) 10.2 (4.8) 7.6 (2.3) 27.6 (4.6) 17.4 (2.5) 
Female 6.1 (2.9) 19.8 (18.9) 24.2 (11.5) 9.0 (8.4) 7.7 (2.3) 
Total 6.1 (2.1) 14.8 (9.5) 14.3 (5.5) 27.0 (4.5) 12.4 (1.7) 
                                  * Post-BD FEV1/FVC < 70% and post-BD FEV1 < 80% predicted 
 
 
Table 6. Prevalence of current smoking by age and sex in Tirana, Albania 
 
    Age-group    





Male 40.5% 44.6% 29.3% 21.0% 35.8% 
Female 7.8% 8.4% 5.3% 3.0% 7.3% 
Total 22.5% 23.6% 19.9% 15.8% 21.6% 






















* Non-weighted data for the sample of responders.  
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Table 7. Estimated Population Prevalence (SE) of Doctor-Diagnosed COPD* by age and sex 
in Tirana, Albania 
 
   Age-
group  
  
Sex 40-49 50-59 60-69 70+ Total 
Male 0 1.7 (1.4) 3.8 (1.8) 4.4 (2.6) 1.9 (0.8) 
Female 0 2.3 (0.7) 0 0 0.6 (0.1) 
Total 0 2.0 (0.8) 1.9 (0.9) 2.0 (1.2) 1.3 (0.4) 
                                                        * Includes chronic bronchitis, emphysema or COPD 
 
Discussion  
This is the first COPD prevalence study ever 
conducted in Albania. Response rate for Al-
bania was high, both for males and females, 
82.3%. Response rates among females were 
slightly higher, 84% as compared to 83% for 
males, although not statistically significant. 
We did not observe any difference among the 
responders according to age groups, doctor 
diagnosed asthma, emphysema, chronic 
bronchitis (CB) or COPD, but we found sta-
tistically significant difference in relation to 
smoking status and other co-morbid condi-
tions. The percentage of responders and non-
responders among current smokers was simi-
lar, showing that completing questionnaires 
and performing spirometry was not easy for a 
current smoker. The percentage of never 
smokers for non-responders and responders 
was respectively 73% and 63%, (p<0.001), 
showing that never smokers are less concer-
ned about respiratory health status. Among 
participants with co-morbid conditions, the 
percentage of non-responders and responders 
was respectively 64% and 74%, (p<0.007), 
showing that presence of co-morbid condi-
tions is likely to increase awareness about 
respiratory health status. 
Our study showed that the overall COPD 
prevalence (GOLD stage 1 or higher) in Al-
bania was 12.4%, and was higher in males 
(17.4%) than females (7.7%) and in those 
aged > 70 years old. Using Lower Limit of 
Normal (LLN) the prevalence of COPD was 
9.9%, again higher in males (13.2%) than fe-
males (6.6%) and like when using GOLD cri-
teria, was higher in those aged > 70 years old. 
Thus, the prevalence of COPD using LLN 
was lower than the prevalence estimated us-
ing GOLD criteria.  
The Global Initiative for Chronic Obstructive 
Lung Disease (GOLD) uses a fixed ratio of 
FEV1/FVC of 0.7 for the diagnosis of ob-
struction by spirometry, regardless of age, 
sex or height (13). This may result in false-
positive diagnose of COPD in elderly sub-
jects, as the ratio has a small but significant 
age related regression (14). The ATS/ERS 
task force has recommended the use of Lower 
Limit of Normal (LLN) rather than a fixed ra-
tio to avoid overdiagnosis of COPD (15). In 
our study we used LLN for that purpose.  
A literature review of the epidemiology of 
chronic obstructive pulmonary disease 
showed that the prevalence estimates varied 
widely, depending on the methods used for 
diagnosis and classification of COPD (16-
18). The reported prevalence of COPD 
ranged from 0.2% in Japan to 37% in USA 
(19). 
Another systematic review for Europe coun-
tries showed that prevalence estimates varied 
from 2.1% to 26.1%, depending on country, 
age group and methods used (20). 
Comparing our data to the international 
BOLD studies we conclude that COPD pre-
valence in Albania is lower than that reported 
from many other countries like: Austria 
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26.1% (21); Iceland 18% (22); Germany 
13.2% (23), and higher than that of other 
countries like: China 8.2% (24) and Australia 
7.9% (25). 
These geographical differences, despite the 
use of the BOLD protocol, could be at-
tributed to different levels of smoking in the 
local population, or possibly other risk fac-
tors, such as genetic predisposition, occupa-
tion, biomass and air pollution.  
Our study showed a significant correlation 
between age and smoking history expressed 
as pack years (r = 0.500; p < 0.001). The as-
sociation of COPD with old age may be at-
tributed to a greater exposure to risk factors 
(26,27). 
The prevalence of COPD in women in our 
study was lower than in men like in most of 
the countries worldwide due to the fact that 
women traditionally smoke much less than 
men (28). This situation has changed in some 
developed countries, where the prevalence of 
smoking in women is now often as high as 
that in men (29). 
The prevalence of COPD in never smokers 
was surprisingly similar for both men and 
women, which differs from that of most of 
the studies. 
The high prevalence of COPD among women 
in most of the developing countries is at-
tributed to biomass and cooking conditions 
(30-32). In Albania it does not appear to be a 
major contributory factor. 
The prevalence of smoking in our study was 
21.6%. It was higher in males than females, 
35.8% and 7.3% respectively. The highest 
prevalence was in age groups 50-59 and 40-
49 years; there was a trend for smoking ces-
sation with increasing age. We think that this 
fact is related to the co-morbidities that asso-
ciate the age group above 60 years old. An 
important fact is noted in relation to female 
smoking status. In females over 40 years 
smoking was not as prevalent as in males in 
population. This is related to the fact that our 
society is a conservative one. But this trend 
has changed for younger generations: in fe-
males under 40 years old an increase in smok-
ing prevalence was observed. Our study 
showed that the prevalence of smoking was 
17% in group age 20-39, as compared to 
7.3% in other group ages above 40 years old. 
This high percentage was found mainly in the 
urban areas, whereas in rural areas smoking 
prevalence in this group age did not differ 
compared to other group ages. The preva-
lence of COPD in the smoker group (both for-
mer and current smoker) was found to be 
much higher than that in the non smoker 
group. Similar findings were reported in most 
studies and cigarette smoking is the most 
common risk factor for COPD worldwide 
(26,33). 
Consistent with the present understanding of 
the role of smoking, we found a strong dose-
response relationship with pack-years of 
smoking (27,34).  
As found in other studies there was also a 
positive trend with the increasing of pack-
years, confirming smoking as an important 
risk factor for disease development (35,36). 
Our data showed a low prevalence of doctor 
diagnosed COPD reported by participants, 
only     1.3% and this finding was similar to 
most of the countries where under-diagnosis 
of COPD is common (37).  
But there are countries where prevalence of 
doctor-diagnosed COPD was higher like in 
South Arabia 9.8% (38) and in Salzburg, 
Austria 5.6% (39).  
Skipping spirometric confirmation of COPD, 
thus leading to over-diagnosis, might be the 
reason behind reported data in South Arabia 
(38). 
Our data are consistent with those of other 
countries where there is still a high level of 
under-diagnosis. The need for spirometry 
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testing should be brought to the attention 
of primary care physicians. 
Our study has several strengths. This is the 
first study conducted in Balkan areas using 
BOLD protocol. Moreover, we applied the 
BOLD protocol with standardized methodol-
ogy and high-quality post-BD spirometry. 
Such standardized methodology included 
standardized spirometry equipment, meticu-
lous quality control measures, standard pro-
tocols, validated questionnaires and standard 
data recording, reporting and analysis. 
Moreover, the use of a large sample size rep-





We found that the prevalence of COPD 
among adults in Albania was high, with an 
estimated prevalence of 12.4% in adults ≥40 
years old; 17.4% and 7.7% in men and 
women respectively. Using LLN, the preva-
lence of COPD was lower, 9.9% (13.2% and 
6.6% in men and women respectively).  
COPD prevalence was strongly related to 
smoking and national smoking cessation pol-
icies are needed.  
Doctor diagnosed COPD reported by the par-
ticipants was very low. These numbers 
clearly show a high degree of COPD under-
diagnosis and highlight the need to improve 
physicians’ knowledge about COPD diagno-
sis and greater use of spirometry
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